Researcher Christopher Stroupe at School of Medicine, University of Virginia, has his eye on six little molecules that could be the key to new treatments for both Ebola and cancer. The molecules, which act together as a single unit known as HOPS, are essential for Ebola to infect cells and for cancer cells to grow and survive. As such, they represent a shared weakness – a weakness Stroupe is seeking to exploit. To do that, he is creating a new tool to produce a purified form of HOPS that would facilitate the development of drugs targeting the molecules. By blocking HOPS in human cells, he hopes, doctors can cut the legs from under Ebola and cancer.
Full story can be found from University of Virginia website.